Creating cell banks for vaccine development to prepare for pandemics
Official title: Task V26: MASTER CELL BANKS MANUFACTURING FOR PANDEMIC PREPAREDNESS
Funded at International AIDS Vaccine Initiative · NIH-10168829 · Data updated 2026-11-12
This study is working on making special cell banks to help create new vaccines that can protect people from infectious diseases, including those that might come from bioterrorism, so that we can respond quickly during health emergencies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2020 |
| Award (this year) | $21,065 |
| NIH project number | 272201800010I-0-759302000002-1 |
| Project ID | NIH-10168829 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk of exposure to infectious diseases or those living in areas prone to outbreaks.
✕Less likely to help
Patients with established immunity to specific infectious diseases or those not at risk of exposure may not receive direct benefits from this research.
What this research studies
This research focuses on developing and manufacturing cell banks that are essential for creating vaccines against infectious diseases, including those that may arise from bioterrorism. It involves planning and optimizing vaccine production processes, ensuring compliance with regulatory standards, and conducting necessary audits. Patients may benefit from the development of new vaccines that could protect against emerging infectious diseases. The project aims to streamline the vaccine development process to ensure rapid response during health crises.
Why it matters
Potential benefit: If successful, this research could lead to the rapid development of effective vaccines for infectious diseases, enhancing public health preparedness.
How similar studies have gone: Previous research has shown success in vaccine development through similar manufacturing and characterization approaches, indicating a promising pathway for this project.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Researchers
- Principal investigator: Hassel, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassel, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Developing vaccines and biologics for infectious diseases
This study is working on creating and improving vaccines to help protect people from infectious diseases like the flu and Nipah virus, so that patients can have better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Developing and producing new vaccines for infectious diseases.
This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
New mRNA vaccines to prevent tuberculosis for adolescents and adults
A new mRNA vaccine approach aims to prevent TB in teens and adults and reduce transmission, using advanced vaccine technology.
-
New mRNA Vaccines for Tuberculosis
This research explores new mRNA vaccine technology to protect adolescents and adults from tuberculosis, a serious lung infection.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.